AI search shifts pharma marketing toward generative engine optimization, GCI Health executive says

40 million people search ChatGPT for health information daily, and 40% of U.S. physicians use AI tools to guide clinical decisions. Pharma brands that don't appear in AI-generated answers lose the conversation to competitors.

Categorized in: AI News Marketing
Published on: May 19, 2026
AI search shifts pharma marketing toward generative engine optimization, GCI Health executive says

AI Search Is Forcing Pharma to Rethink How It Reaches Patients and Doctors

Forty million people search ChatGPT for health information every day. Forty percent of U.S. physicians use OpenEvidence-ChatGPT for doctors-to inform clinical decisions. This shift has created a zero-click environment where pharmaceutical brands either appear in AI-generated answers or they don't.

The change is forcing marketers to abandon traditional engagement models. When 69% of users no longer click through to websites after reading AI search results, visibility in those results becomes the priority.

Patients Are Making Treatment Decisions Based on AI Answers

A survey of U.S. physicians found that 90% reported patients arriving with questions informed by ChatGPT. The effect cuts both ways. While AI search can empower patients to ask better questions, 68% of surveyed physicians said patients questioned or refused treatment based on AI-generated information.

The risk is real: patients may encounter inaccurate or incomplete information that steers them away from appropriate options. Brands that don't appear in those answers cede the conversation to competitors.

Generative Engine Optimization Is No Longer Optional

Generative engine optimization (GEO) is the new capability pharma communicators must master. Unlike traditional search engine optimization, GEO focuses on making content discoverable by large language models-the systems generating those answers patients trust.

The logic is straightforward: there are infinite patient questions but finite answers to them. A brand either appears in the answer or it doesn't. If competitors control the answer space, they control the conversation.

Actionable steps include auditing where your brand currently appears in AI search results, identifying which competitors are cited most often, and prioritizing the two or three content opportunities that will drive the highest impact. For some organizations, this means rethinking how press releases are written. For others, it involves reconsidering which journals to publish in or which journalists to pitch.

Media Diets Are Shrinking, But Trust Is Concentrating

While noise and clutter in the information environment continue to grow, people are retreating to the same four or five trusted sources. ChatGPT, Google, and Claude dominate that list.

This concentration means pharma content that isn't discoverable by these platforms essentially doesn't exist. Competitors who optimize for GEO capture share of voice that may take months or years to reclaim.

Curiosity and Adaptability Separate Winners From the Rest

The best marketers throughout history have mastered the tools of their time-from the printing press to cable news to social media. Today's equivalent is GEO and AI-driven search.

The limiting factor isn't access to tools. It's curiosity. Brands that ask questions about how patients and physicians search, how AI systems rank information, and where competitors are winning will adapt faster than those treating GEO as an afterthought.

The game is in its early innings. Brands that build competency now will have structural advantages as AI search becomes the default way people seek health information.

Related: Learn more about ChatGPT Courses and AI for Marketing to develop skills in this emerging space.


Get Daily AI News

Your membership also unlocks:

700+ AI Courses
700+ Certifications
Personalized AI Learning Plan
6500+ AI Tools (no Ads)
Daily AI News by job industry (no Ads)